We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
115 hedge funds and large institutions have $1.92B invested in Atara Biotherapeutics in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
62% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 26
13% more capital invested
Capital invested by funds: $1.7B → $1.92B (+$213M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.14% less ownership
Funds ownership: 4.23% → 4.09% (-0.14%)
7% less funds holding
Funds holding: 124 → 115 (-9)
29% less call options, than puts
Call options by funds: $3.53M | Put options by funds: $4.96M
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
115
Holders Change
-9
Holders Change %
-7.26%
% of All Funds
2.63%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
42
Reduced
26
Closed
22
Calls
$3.53M
Puts
$4.96M
Net Calls
-$1.43M
Net Calls Change
-$3.82M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$12.4M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$9.72M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.65M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.49M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.96M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.3M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$11.6M |
| 3 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$6.95M |
| 4 |
Morgan Stanley
New York
|
-$5.94M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$5M |
